UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 721

Sortiert nach

Serotonin-1A Receptor Gene HTR1A Variation Predicts Interferon-Induced Depression in Chronic Hepatitis C

Gastroenterology (New York, N.Y. 1943), 2007-04, Vol.132 (4), p.1279-1286

2007

Volltextzugriff (PDF)

Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C

World journal of gastroenterology : WJG, 2005-03, Vol.11 (12), p.1769

2005

Volltextzugriff (PDF)

Only partial improvement in health‐related quality of life after treatment of chronic hepatitis C virus infection with direct acting antivirals in a real‐world setting—results from the German Hepatitis C‐Registry (DHC‐R)

Journal of viral hepatitis, 2021-08, Vol.28 (8), p.1206-1218

2021

Volltextzugriff (PDF)

Differential effects of PPARγ activation by the oral antidiabetic agent pioglitazone in Barrett's carcinoma in vitro and in vivo

Journal of gastroenterology, 2009-09, Vol.44 (9), p.919-929

2009

Volltextzugriff (PDF)

Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy

The journal of clinical psychiatry, 2003-06, Vol.64 (6), p.708

2003

Volltextzugriff (PDF)

Deterioration of health-related quality of life and fatigue in patients with chronic hepatitis C: Association with demographic factors, inflammatory activity, and degree of fibrosis

Journal of hepatology, 2008-12, Vol.49 (6), p.923-929

2008

Volltextzugriff (PDF)

Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: A naturalistic study in 2694 patients

Drug and alcohol dependence, 2008-06, Vol.95 (3), p.245-257

2008

Volltextzugriff (PDF)

Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression

Journal of hepatology, 2010-01, Vol.52 (1), p.10-15

2010

Volltextzugriff (PDF)

Neurocognitive Changes in Patients with Hepatitis C Receiving Interferon alfa-2b and Ribavirin

Clinical pharmacology and therapeutics, 2005-01, Vol.77 (1), p.90-100

2005

Volltextzugriff (PDF)

Improvement of Hepatic and Extrahepatic Complications from Chronic Hepatitis C After Antiviral Treatment: A Retrospective Analysis of German Sickness Fund Data

Infectious diseases and therapy, 2018-09, Vol.7 (3), p.339-352

2018

Volltextzugriff (PDF)

Clinical and Economic Burden of Hepatic and Extrahepatic Complications from Chronic Hepatitis C: A Retrospective Analysis of German Sickness Fund Data

Infectious diseases and therapy, 2018-09, Vol.7 (3), p.327-338

2018

Volltextzugriff (PDF)

High recurrence rate of Barrett's epithelium during long-term follow-up after argon plasma coagulation

Scandinavian journal of gastroenterology, 2007, Vol.42 (1), p.23-27

2007

Volltextzugriff (PDF)

Methodological approaches in the assessment of interferon-alfa-induced depression in patients with chronic hepatitis C - a critical review

International journal of methods in psychiatric research, 2007-12, Vol.16 (4), p.186-201

2007

Volltextzugriff (PDF)

Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy

Addiction (Abingdon, England), 2009-04, Vol.104 (4), p.630-640

2009

Volltextzugriff (PDF)

Nucleoporin p62 Antibodies in a Case of Mixed Connective Tissue Disease

Clinical and Diagnostic Laboratory Immunology, 2003-03, Vol.10 (2), p.329-331

2003

Volltextzugriff (PDF)

Physician–patient relationship and disclosure behaviour in chronic hepatitis C in a group of German outpatients

European journal of gastroenterology & hepatology, 2005-12, Vol.17 (12), p.1387-1394

2005

Volltextzugriff (PDF)

Sustained Virological Response in the Antiviral Therapy of Chronic Hepatitis C: Is There a Predictive Value of Interferon-Induced Depression?

Chemotherapy (Basel), 2007-01, Vol.53 (4), p.292-299

2007

Volltextzugriff (PDF)

Reply

Hepatology (Baltimore, Md.), 2014-07, Vol.60 (1), p.431

2014

Volltextzugriff (PDF)

Reply

Hepatology (Baltimore, Md.), 2014-07, Vol.60 (1), p.431-432

2014

Volltextzugriff (PDF)

Reply

Hepatology (Baltimore, Md.), 2014-07, Vol.60 (1), p.431-432

2014

Volltextzugriff (PDF)

Buprenorphine and methadone in the treatment of opioid dependence: methods and design of the COBRA study

International journal of methods in psychiatric research, 2005-02, Vol.14 (1), p.14-28

2005

Volltextzugriff (PDF)

THU-115-Effects of health-related quality of life of interferon-free antiviral therapy for chronic hepatitis C infection-Results from the GermanhHepatitis C-Registry (DHC-R)

Journal of hepatology, 2019-04, Vol.70 (1), p.e208-e209

2019

Volltextzugriff (PDF)

Effectiveness and Safety of Direct-Acting Antiviral Combination Therapies for Treatment of Hepatitis C Virus in Elderly Patients: Results from the German Hepatitis C Registry

Drugs & aging, 2018-09, Vol.35 (9), p.843-857

2018

Volltextzugriff (PDF)

Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C‐Registry

Hepatology communications, 2022-09, Vol.6 (9), p.2488-2495

2022

Volltextzugriff (PDF)

1 – 25 von 721

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(657)
Mit Volltextzugriff
(628)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Serotonin-1A Receptor Gene HTR1A Variation Predicts Interferon-Induced Depression in Chronic Hepatitis C

Treatment Extension of Pegylated Interferon Alpha and Ribavirin Does Not Improve SVR in Patients with Genotypes 2/3 without Rapid Virological Response (OPTEX Trial): A Prospective, Randomized, Two-Arm, Multicentre Phase IV Clinical Trial

Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C

Only partial improvement in health‐related quality of life after treatment of chronic hepatitis C virus infection with direct acting antivirals in a real‐world setting—results from the German Hepatitis C‐Registry (DHC‐R)

Differential effects of PPARγ activation by the oral antidiabetic agent pioglitazone in Barrett's carcinoma in vitro and in vivo

Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy

Deterioration of health-related quality of life and fatigue in patients with chronic hepatitis C: Association with demographic factors, inflammatory activity, and degree of fibrosis

Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: A naturalistic study in 2694 patients

Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression

Neurocognitive Changes in Patients with Hepatitis C Receiving Interferon alfa-2b and Ribavirin

Improvement of Hepatic and Extrahepatic Complications from Chronic Hepatitis C After Antiviral Treatment: A Retrospective Analysis of German Sickness Fund Data

Clinical and Economic Burden of Hepatic and Extrahepatic Complications from Chronic Hepatitis C: A Retrospective Analysis of German Sickness Fund Data

High recurrence rate of Barrett's epithelium during long-term follow-up after argon plasma coagulation

Methodological approaches in the assessment of interferon-alfa-induced depression in patients with chronic hepatitis C - a critical review

Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy

Nucleoporin p62 Antibodies in a Case of Mixed Connective Tissue Disease

Physician–patient relationship and disclosure behaviour in chronic hepatitis C in a group of German outpatients

Sustained Virological Response in the Antiviral Therapy of Chronic Hepatitis C: Is There a Predictive Value of Interferon-Induced Depression?

Reply

Reply

Reply

Buprenorphine and methadone in the treatment of opioid dependence: methods and design of the COBRA study

THU-115-Effects of health-related quality of life of interferon-free antiviral therapy for chronic hepatitis C infection-Results from the GermanhHepatitis C-Registry (DHC-R)

Effectiveness and Safety of Direct-Acting Antiviral Combination Therapies for Treatment of Hepatitis C Virus in Elderly Patients: Results from the German Hepatitis C Registry

Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C‐Registry

Suchergebnisse filtern